FDA News

FDA designates recall of balloon embolectomy catheter as class 1

April 3, 2020
The FDA has identified the recall of LeMaitre Vascular’s balloon embolectomy catheter as class 1, the most serious kind, due to risk for death…

Meeting NewsPerspective

Low-dose rivaroxaban reduces risk in PAD post-revascularization

March 28, 2020
In the VOYAGER PAD trial, patients with symptomatic peripheral artery disease who underwent lower-extremity revascularization had a lower incidence…


Cath lab concerns prompted by COVID-19

March 25, 2020
As more is learned about the COVID-19 pandemic, cardiology societies have issued advisories with steps to take in the cardiac catheterization…

The Take Home

The Take Home: ISET

February 18, 2020
The International Symposium on Endovascular Therapy, held Jan. 22 to 25 in Hollywood, Florida, tackled many of the hottest topics in endovascular…

In the Journals

No 5-year mortality signal in trial of PCB for below-the-knee lesions

February 17, 2020
A paclitaxel-coated balloon was not associated with elevated mortality risk in patients who underwent revascularization for critical limb ischemia…

In the Journals

Cocoa may improve walking ability in patients with PAD

February 14, 2020
Daily consumption of cocoa with epicatechin improved 6-minute walk distance, blood flow to the legs and skeletal muscle health in patients with…

In the Journals

Subsequent risk elevated after hospitalization for major adverse limb events

February 12, 2020
Among patients who underwent peripheral artery revascularization, those who were subsequently hospitalized at least once for a major adverse limb…

Meeting News

Low-dose paclitaxel-coated balloon noninferior to higher-dose balloon

February 6, 2020
A low-dose paclitaxel-coated balloon was similar in safety and efficacy to a higher-dose one for treatment of patients with peripheral artery…

Meeting News

PCB for below-the-knee lesions does not confer long-term safety concern

February 5, 2020
A paclitaxel-coated balloon for treatment of below-the-knee lesions was not associated with excess mortality or amputation risk at 3 years…

Meeting News

ILLUMENATE: DCB effective at 4 years with no mortality hazard

February 1, 2020
A paclitaxel-coated balloon was safe and effective in patients with peripheral artery disease at 4 years and did not confer elevated mortality risk…

Meeting News

Meta-analysis of paclitaxel-coated balloons in CLI ‘should have no meaningful impact’

January 31, 2020
A recent meta-analysis detecting a signal of harm at 1 year in patients with below-the-knee lesions treated with paclitaxel-coated balloons is flawed…

Meeting News

Real-world studies show no mortality signal related to paclitaxel-coated devices

January 29, 2020
Unlike with meta-analyses of randomized controlled trials, seven real-world studies of patients with peripheral artery disease have shown no…

LIBERTY 360°: Regardless of PAD severity, endovascular interventions helpful at 3 years

January 28, 2020
At 3 years, patients with various stages of peripheral artery disease who underwent endovascular interventions had high rates of freedom from adverse…

Meeting News

Long-term mortality after CLI diagnosis high, urgent action needed

January 27, 2020
The 4-year mortality rate after a diagnosis of critical limb ischemia is more than 50%, comparable to the deadliest cancers, which demands a…

Meeting News

FDA: Paclitaxel device use requires risk-benefit discussion with patients

January 24, 2020
Despite being associated with a long-term mortality signal, paclitaxel-coated devices are staying on the market because benefits outweigh risks for…

Meeting News

Medical therapy beneficial in PAD, but underprescribed

January 23, 2020
There is now plentiful evidence that medical therapy benefits patients with peripheral artery disease, which is reflected in guidelines but not…

Top intervention news of 2019: ISCHEMIA trials, low-risk TAVR, paclitaxel debate and more

January 18, 2020
Healio and Cardiology Today compiled a list of the most-read cardiac and vascular intervention articles published in 2019. Readers were interested in…

In the JournalsPerspective

Meta-analysis: Paclitaxel-coated balloons may be harmful in below-the-knee lesions

January 15, 2020
A systematic review and study-level meta-analysis of randomized controlled trials of treatment of infrapopliteal arteries found that…

FDA News

FDA designates recall of support catheter as class 1

December 17, 2019
The FDA has designated Cook Medical’s product recall of a support catheter as a class 1 recall, the most serious kind. The recall affects 117…

Meeting News

Top stories from VIVA: Peripheral DES, drug-coated balloons and more

December 1, 2019
Healio and Cardiology Today present meeting highlights from VIVA 19 in Las Vegas. Top stories included the latest from the IMPERIAL head-to-head…